After 16 weeks, patients on Rozebalamin had experienced a 43% lower decline in ALSFRS-R scores, indicating a significant slowing in disease progression, compared with a placebo
If using a detachable needle, a tiny bit of fluid can remain in the needle hub
J., & Patel, V
Overcoming access challenges with transitional assistance The market access environment for new launch products has become progressively restrictive with payers enforcing more prior authorizations, step edits, and blocks than ever before
This medication works by stimulating insulin release, inhibiting glucagon secretion, reducing gastric emptying, and decreasing appetite and food cravings
Approximately 50-60% of diabetic patients on Tirzepatide reach A1C levels below 5.7%, essentially achieving diabetes remission while on treatment